To investigate whether miR-145 is involved in AR-enhanced RCC invasion, we applied interruption approaches and found that exogenous expression of miR-145 led to partially reverse the AR-enhanced RCC cell invasion (Figure 3A, AR+miR-145 vs. AR+NC, NC = negative control). The gene discussed is AR; the disease is renal cell carcinoma.